学术探索
学术期刊
新闻热点
数据分析
智能评审

Chemotherapy: What progress in the last 5 years?

被引：76
作者：
Hamilton, A
Hortobagyi, G
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[2] Sydney Canc Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW 2006, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期
关键词：
D O I：
10.1200/JCO.2005.10.034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1760 / 1775
页数：16
相关论文
共 152 条
  • [1] Abe O, 1998, LANCET, V352, P930
  • [2] Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors:: 5-year follow-up results of French adjuvant study group 05 randomized trial
    Adenis, A
    Bonneterre, J
    Bonneterre, ME
    Pion, JM
    Vanlemmens, L
    Gladieff, L
    de Lafontan, B
    Martel, P
    Mihura, J
    Roché, H
    Gédouin, D
    Kerbrat, P
    Lesimple, T
    Brémond, A
    Devaux, Y
    Delecroix, V
    Fumoleau, P
    Maugard-Louboutin, C
    Namer, M
    Goudier, MJ
    Morice, F
    Montcuquet, P
    Schraub, S
    Coudert, B
    Fargeot, P
    de Gislain, C
    Mayer, F
    Bastit, P
    Chevallier, B
    Grandgirard, A
    Monnier, A
    Sun, X
    Clavère, P
    Ollivier, JP
    Rhein, B
    Roullet, B
    Datchary, J
    Audhuy, B
    Barats, JC
    Kohser, F
    Dides, S
    Ramos, R
    Cattan, A
    Eymard, JC
    Pourny, C
    Weber, B
    de Laroche, G
    Pichon, A
    Seffert, P
    Hayat, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 602 - 611
  • [3] Albain KS, 2004, J CLIN ONCOL, V22, p5S
  • [4] Neoadjuvant chemotherapy for stage III breast cancer:: does the addition of paclitaxel to doxorubicin increase complete response.: A single institution non randomized study
    Alvarez, A
    Rodger, J
    Brosio, C
    Cinat, G
    Giglio, R
    Carnaval, S
    Morgado, CC
    Noblía, C
    Delfino, C
    Mickiewicz, E
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S73 - S73
  • [5] Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate
    Amat, S
    Bougnoux, P
    Penault-Llorca, F
    Fétissof, F
    Curé, H
    Kwiatkowski, F
    Achard, JL
    Body, G
    Dauplat, J
    Chollet, P
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (09) : 1339 - 1345
  • [6] ANELLI A, 1999, P AN M AM SOC CLIN, V18, pA80
  • [7] [Anonymous], 1988, NEW ENGL J MED, V319, P1681
  • [8] [Anonymous], 1992, Lancet, V339, P1
  • [9] [Anonymous], P AM SOC CLIN ONCOL
  • [10] [Anonymous], [No title captured]
12345678910